Aflibercept monotherapy effectively rescues eyes first treated with bevacizumab
- Posted on: Aug 30 2022
- Leave a response
This study compared the outcomes of patients who received aflibercept from the outset of treatment for DME to those who first received bevacizumab and then were switched after 12 weeks.
Source: AAO
Posted in: Uncategorized
